752244-29-4

Basic information

• Product Name: (2R,6S)-2,6-dimethyltetrahydro-4H-pyran-4-one
• Synonyms: (2R,6S)-2,6-dimethyltetrahydro-4H-pyran-4-one
• CAS NO: 752244-29-4
• Molecular Weight: 128.171
• Mol File: 752244-29-4.mol
• Article Data: 25

Chemical Properties

• CAS DataBase Reference: (2R,6S)-2,6-dimethyltetrahydro-4H-pyran-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: (2R,6S)-2,6-dimethyltetrahydro-4H-pyran-4-one(752244-29-4)
• EPA Substance Registry System: (2R,6S)-2,6-dimethyltetrahydro-4H-pyran-4-one(752244-29-4)

Safety Data

• Hazardous Substances Data: 752244-29-4(Hazardous Substances Data)

Upstream product

• 16000-13-8 2,6-dimethyl-2,3-dihydro-pyranone 
• 155206-70-5 (4E)-4-Ethoxyhepta-4,6-dien-2-ol 
• 869293-25-4 (R)-5-((tert-butyldimethylsilyl)oxy)hex-1-en-3-one 
• 190912-17-5 (R)-2-methyl-2,3-dihydro-4H-pyran-4-one 
• 676-58-4 methylmagnesium chloride 
• 33747-09-0 (2R,4S,6S)-2,6-dimethyltetrahydro-2H-pyran-4-ol 
• 1004-36-0 2,6-dimethylpyrone 
• 122222-69-9 5-t-butoxycarbonyl-2,6-dimethyl-2,3-dihydro-4H-pyran-4-one 
• 64-17-5 ethanol 

Downstream Products

• 156407-31-7 (2S,4S,6R)-2,6-Dimethyl-4-[3-(tetrahydro-pyran-2-yloxymethyl)-phenyl]-tetrahydro-pyran-4-ol 
• 1620450-76-1 C₁₈H₂₃NO₅ 

Relevant articles and documents

1,1-Diethoxybut-2-ene as a Precursor of (2-Hydroxyethyl)-Substituted Alkoxy Dienes: Convenient Intermediates for a New Synthesis of 2-Substituted and 2,6-Disubstituted Tetrahydro-4H-pyran-4-ones

-

INHIBITOR OF BTK AND MUTANTS THEREOF

The disclosure includes compounds of Formula (I) (1) wherein Q0, Q1, Q2, Q3, Q4, Z, W, i, j, m, n, Warhead, R0, R1, R3, R4, R5, R6, and R7, are defined herein. Also disclosed is a method for treating a neoplastic disease, autoimmune disease, and inflammatory disorder with these compounds.

PIPERAZINE DERIVATIVES AS HIV PROTEASE INHIBITORS

The present invention is directed to compounds of Formula I pharmaceutical compositions comprising the same, and their use in the inhibition of HIV protease, the inhibition of HIV replication, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS.